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Abstract
Staphylococcus aureus a-toxin forms heptameric pores on eukaryotic cell membranes. Assembly of the heptamer
precedes formation of the transmembrane pore. The latter event depends on a conformational change that drives a centrally
located stretch of 15 amino acid residues into the lipid bilayer. A second region of the molecule that has been implicated in
the pre-pore to pore transition is the far N-terminus. Here, we used fluorescently labeled single cysteine replacement
mutants to analyze the functional role of the far N-terminus of a-toxin. Pyrene attached to mutants S3C, I5C and I7C forms
excimers within the toxin pore complex. This indicates that the distance of adjacent N-termini is less than 10–12 Angstrom.
By labeling with the polarity-sensitive fluorophore acrylodan, pore formation is shown to cause distinct environmental
changes in the N-terminus. Removal of membrane lipids from the labeled heptamers has no effect upon the acrylodan
spectrum, indicating lack of direct contact of the N-terminus with the target membrane. The environmental alterations to the
N-terminus are thus due to altered protein structure only. Both acrylodan emission shifts and pyrene excimers were shown
to be absent in toxin heptamers that were arrested at the pre-pore stage. Therefore, while not being directly involved in
membrane penetration, the N-termini of the a-toxin heptamer subunits move into immediate mutual proximity concomi-
tantly with transmembrane pore formation.
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1. Introduction
Staphylococcus aureus a-toxin serves as a proto-
type for the study of pore formation by proteinaceous
w xtoxins in lipid bilayers 1–4 . The toxin is secreted as
a hydrophilic molecule of 293 amino acids lacking
Abbreviations: cps, counts per second; DOC, sodium deoxy-
 .cholate; S3C I5C, I7C, H35R , a-toxin mutant with cysteine
 .  .arginine instead of serine isoleucine, histidine at amino acid
 .position 3 5, 7, 35
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w xcysteine 5 , and binds in monomeric form to target
membranes. Collision of bound monomers ultimately
results in formation of tightly associated heptamers
surrounding a central transmembrane pore. The hep-
tamer is arrested at the stage of a non-lytic pre-pore
at 48C. Similar effects are observed after different
w xamino acid substitutions 6,7 and with truncation
w xmutants 8 . Exposure to the detergent deoxycholate
has been shown to cause slow transformation of
w xmonomers to heptamers 9 .
The toxin molecule has been scanned for func-
tional domains by construction of 41 point mutants
carrying single cysteine residues at various positions
of the sequence. The cysteines were labeled with the
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environmentally sensitive fluorophore acrylodan, and
environmental changes to the labeled residues accom-
panying pore-formation were detected by shifts of the
acrylodan emission. This led to identification of
residues 126–140 as the a domain that lines the
w xtransmembrane pore 10 .
Within this membrane-inserting loop at residue
.K131 , there is a site of preferential tryptic cleavage
of the toxin monomer. This cleavage site becomes
inaccessible concomitantly with toxin pre-pore as-
w xsembly 8 . A second site at residue K8 differs from
the first one by remaining accessible in the pre-pore
form of the heptamer, suggesting a role for the far
N-terminus of the toxin molecule in the pre-pore to
pore transition, possibly by direct interaction with the
target lipid bilayer. By contrast, an engineered cys-
teine replacing amino acid S3 remains accessible to
hydrophilic reagents in the pore, suggesting that it
w xdoes not enter the lipid bilayer 11 .
The present study was performed to gain more
information on the structural and functional roles of
the far N-terminus. To this end, three N-terminally
located single cysteine mutants were constructed and
derivatized with fluorescent probes detecting protein
contact and environmental alterations. The collective
data confirm that the N-terminus is involved in the
pre-pore to pore transition. By contrast with the
central loop, it does not enter the lipid bilayer. Rather,
the N-terminus undergoes a profound conformational
change that takes adjacent subunits of the heptamer
into immediate mutual contact.
2. Materials and methods
2.1. Mutagenesis and cloning
The cysteine mutations were generated by PCR
w xmutagenesis according to published procedures 12 .
The mutant PCR products were cloned into the plas-
w xmid pDU 1212 13 to allow for their expression in S.
aureus.
2.2. Toxin isolation
Wild-type a-toxin and mutant toxins were isolated
w xas described 14 . Briefly, the a-toxin negative S.
w xaureus strain DU 1090 13 was transfected with
mutant derivatives of pDU1212 and grown in 2 l of
2)TY broth. Protein from culture supernatants was
concentrated and transferred into 20 mM ammonium
acetate pH 5.8 by membrane filtration and the mutant
toxins purified by ion exchange chromatography on
 .S-Sepharose FF Pharmacia, Freiburg, Germany .
 .Proteins were stored with 5 mM dithiothreitol DTT
at y708C.
2.3. Labeling of sulfhydryl groups
The mutant proteins were thiol-specifically labeled
with either N-3X-pyrenyl-maleimide or 6-acryloyl-2-
dimethyl-amino-naphthalene acrylodan; both from
. w xMolecular Probes, Eugene, OR as described 10 . To
remove excess label, the protein was applied to a
 .column of hydroxyapatite Biogel HTP, Bio-Rad ,
rinsed for 1 h with 20 mM sodium phosphate, pH
7.2, and eluted with 75 mM sodium phosphate. The
stoichiometry of labeling was assessed spectrophoto-
 w x .metrically see 10 for details . Wild type a-toxin
treated in parallel with the mutants was modified
neither by acrylodan nor N-3X-pyrenyl-maleimide. The
activity of the labeled protein was verified by
hemolytic titration carried out in duplicate according
w xto published procedures 2 with wild-type toxin serv-
ing as standard.
2.4. Formation of a-toxin heptamers on liposome
membranes
Liposomes consisting of egg yolk phosphatidyl-
choline, egg yolk phosphatidylglycerol and choles-
 .terol molar ratio 5:1:4 were prepared by sonication
w x as described previously 15 . Labeled toxins 10 mg
.of labeled toxin, if not stated otherwise were incu-
bated with liposomes at a toxin: lipid ratio of 1:10 by
weight.
Where formation of pre-pores was desired, the
 .incubation was done on ice. Gel filtration see below
was carried out to verify formation of heptamers.
These were dissociated to monomers on SDS-PAGE
at room temperature, which is typical of pre-pores as
w xopposed to pores 10 . By contrast, incubation of the
toxins with liposomes at room temperature yielded
SDS-resistant pore heptamers.
The acrylodan-labeled mutants were also co-
oligomerized with unlabeled H35R or wild type toxin
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 .  .to yield either pre-pores H35R or pores wild-type .
Here, the unlabeled species was admixed in tenfold
excess over the labeled one prior to addition of
liposomes.
2.5. Preparation of delipidated acrylodan-labeled a-
toxin oligomers
Liposomes carrying heptamerized toxin mutants
 .100 mg were solubilized with 125 mM sodium
 .deoxycholate DOC and applied to a Sephacryl S-300
column equilibrated with 6.25 mM DOC, 150 mM
NaCl, 20 mM trishydroxymethyl-aminomethane
 .Tris , pH 8.3, to separate oligomers from lipids and
w xresidual monomers 9 . Fractions containing the
oligomers were collected, checked for purity on SDS
gels and used for fluorimetry.
2.6. Spectrofluorimetry
Emission spectra were recorded in a SPEX Fluoro-
max spectrofluorimeter excitation wavelength: 365
nm for acrylodan, 339 nm for pyrene; excitation
.bandpass 4 nm, emission bandpass 2 nm . The appro-
priate buffers and liposome preparations were checked
for the absence of significant fluorescence and used
as blanks.
3. Results
3.1. Construction, labeling and functionality of a-
toxin mutant proteins
The following mutant proteins were constructed
and isolated: S3C, I5C, and I7C. Labeling yields
ranged from 70 to 95%. The pore-forming effect as
.assessed by specific hemolytic activity of labeled
mutants was identical to that of wild-type toxin he-
.molytic titer of a 1 mgrml solution, 1:20 000 .
3.2. The subunits of the toxin pore are in close
proximity at their N-termini
Fig. 1 shows the emission spectra of mutant S3C,
labeled with pyrene maleimide, in monomeric and
liposome-associated heptameric form. In the
Fig. 1. Pyrene excimer formation indicates contact among N-
termini within the a-toxin pore. Mutant S3C was labeled with
pyrene maleimide. Both prior to and after toxin oligomerization
on liposome membranes, the fluorescence emission of pyrene
was recorded. In both experiments, 10 mg of labeled toxin were
used. After pore assembly on membranes, the emission of pyrene
monomers is decreased, and a broad peak around 470 nm emerges.
 .This peak is characteristic of pyrene excited dimers excimers .
oligomer, the emission of monomeric pyrene is
strongly suppressed, and a broad peak around 470 nm
emerges which is characteristic of pyrene excimers.
This indicates that the labeled residues of adjacent
subunits of the heptameric pore are within a distance
w xof less than about 10–12 Angstrom 16 . Equivalent
results were also observed with I5C and I7C data not
.shown .
3.3. Direct interaction of adjacent acrylodan
molecules results in fluorescence quenching
The mutant proteins were also labeled with the
polarity-sensitive dye acrylodan. The labeled toxins
were transformed to heptamers by incubation with
liposomes. Matching samples were prepared by using
identical amounts of labeled toxin admixed with un-
.labeled wild-type toxin in excess. For mutant S3C,
Fig. 2 gives the spectra of both homogeneous and
hybrid heptamers. The fluorescence intensity of
acrylodan is strongly quenched in the homogeneous
oligomers. In addition, the emission maximum is
blue-shifted, probably indicating a mutual hydropho-
bic interaction of adjacent acrylodan molecules. Simi-
lar results were obtained with I5C and I7C not
.shown . To eliminate these extrinsic environmental
changes to the probe, all further heptamer acrylodan
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Fig. 2. The fluorescence of N-terminally attached acrylodan is
self-quenched in the heptameric pore. Mutant S3C was labeled
with the polarity-sensitive fluorescent dye acrylodan. 5 mg of the
 .labeled protein S3C was oligomerized on membranes. A paral-
lel sample containing the same amount of labelled toxin was
supplemented with unlabeled wild type toxin in excess to effect
spatial separation of acrylodan molecules in the heptamer
 .S3Crwild type . The emission spectra of both types of hep-
tamers were recorded. Immediate contact among acrylodan
molecules results in a pronounced decrease of fluorescence inten-
sity. In addition, the emission maximum is blue-shifted, indicat-
ing a mutual influence upon environmental polarity of adjacent
acrylodan molecules.
spectra were acquired with samples containing unla-
beled toxin in excess.
3.4. En˝ironmental effects of pore-formation to the
N-terminus of a-toxin
Fig. 3A displays the acrylodan emission spectra of
S3C monomers and membrane-bound as well as de-
oxycholate-solubilized heptamers. Oligomerization on
membranes is accompanied by a distinct blue shift in
acrylodan emission, which indicates a more hy-
drophobic environment of the label in the heptamer.
The heptamer spectrum is not affected by removal of
membrane lipids by detergent, which indicates lack
of direct interaction between label and lipid bilayer.
Residue S3C thus does not penetrate the target mem-
brane during pore formation. Therefore, the environ-
mental difference between monomers and heptamers
is due to the contact of subunits in the oligomer and,
possibly, altered conformation of the individual sub-
unit. Less pronounced but entirely consistent effects
 .were observed with mutant I5C not shown . By
contrast to the above two mutants, mutant I7C dis-
plays a distinct emission red shift upon pore forma-
 .tion Fig. 3B , which is not sensitive to deoxycholate
solubilization either.
3.5. The spectral effects to the N-terminus occur with
the pre-pore to pore transition
The above results relate only to the first and the
last stage of pore assembly, i.e. to the monomer and
the heptameric pore. To examine the N-terminus
within the pre-pore, the acrylodan-labeled cysteine
mutants were co-oligomerized with the non-lytic toxin
Fig. 3. Environmental effects to the N-terminus accompanying
pore-formation. A. The far N-terminus is not involved in contact
with the lipid bilayer. Acrylodan-labeled S3C toxin was co-
 .oligomerized with unlabeled toxin in excess cf. Fig. 2 . The
emission maximum of the heptamers on membranes is blue-shifted
with respect to the monomer in solution, indicating a more
hydrophobic environment in the heptamer. The heptamer emis-
sion is not affected by removal of the membrane lipids with
 .deoxycholate DOC , indicating lack of direct contact between
label and membrane. The hydrophobic environment of the label
is therefore afforded by the heptamer itself. B. The emission of
acrylodan-labeled mutant I7C is red-shifted when the monomer
forms heptamers on membranes. This emission red shift indicates
a more hydrophilic environment of residue 7 in the heptamer.
 .Spectra are normalized to the same maximum intensity .
( )A. Vale˝a et al.rBiochimica et Biophysica Acta 1325 1997 281–286 285
Fig. 4. The N-terminus is involved in the pre-pore to pore
transition. A: Acrylodan emission spectra of S3C monomers,
 .pore heptamers S3Crwild type , and pre-pore heptamers
 .S3CrH35R . The emission blue-shift characteristic of pore-for-
mation is largely absent from the pre-pore, indicating that the
environmental change to the N-terminus has not yet occurred.
 .Spectra are normalized to the same maximum intensity . B:
Pyrene spectra of labeled I7C monomers, pore heptamers, and
pre-pore heptamers. No pyrene excimers are formed in the pre-
pore, indicating lack of direct contact among adjacent N-termini
within the pre-pore. Spectra are normalized to the same average
.intensity .
mutant H35R in excess. This has been found to result
in hybrid heptamers which are arrested in the pre-pore
w xstage 10 . Fig. 4A gives the spectrum of S3CrH35R
pre-pore oligomers. The emission maximum assumes
the same position as that of the monomer, indicating
that the environmental alteration has not yet occurred
at this stage. Again, equivalent data were obtained
with I5C and I7C.
Pre-pores were also produced of pyrene-labeled
mutant proteins by incubation with liposomes on ice
for 30 min. Oligomerization was verified by gel
filtration on Sephacryl S300; the oligomers were
dissociated by SDS at room temperature as is typical
w xof pre-pores 8 . Fig. 4B gives the pyrene spectrum of
I7C pre-pore heptamers isolated by gel permeation
chromatography. There is virtually no emission
around 470 nm, which means that the N-termini of
the heptamer subunits are not in sufficient proximity
to permit pyrene excimer formation.
4. Discussion
Fluorescent dyes attached to specific sites of pro-
teins are powerful probes that allow for monitoring
w xthe proteins in action. Pyrene maleimide 16 and
w xacrylodan 17 are established probes of spatial prox-
imity or polarity of environment, respectively. When
attached N-terminally to the subunits of the a-toxin
heptamer, they consistently indicated that changes of
both environment and mutual distance accompany the
pre-pore to pore transition. No such changes were
apparent during assembly of the pre-pore, which
therefore does not involve the N-terminus of the
toxin molecule. The same conclusion had previously
w xbeen reached by limited proteolysis 8 .
Despite the functional association of the N-
terminus with membrane permeabilization, it does not
enter the lipid bilayer itself. The pre-pore and the
pore are thus conformationally distinct at sites out-
side the membrane. These different conformations
will persist after removal of membrane lipids, which
explains why both forms are differingly susceptible
to dissociation by SDS.
With a larger series of acrylodan-labeled cysteine
w x w xmutants of a toxin 10 and streptolysin O 18 ,
emission shifts associated with oligomerization have
been found to occur mainly toward shorter wave-
lengths. Where this is not due to immersion of acryl-
odan in the lipid membrane, the label may be pro-
vided with additional hydrophobic surfaces by adja-
cent oligomer subunits. One exception to this rule
was observed here with I7C. Here, the label is ex-
pelled from a hydrophobic environment into a more
hydrophilic one, suggesting lack of contact with adja-
cent protein molecules.
A few experimental details deserve short com-
ment: with the differently labeled toxin heptamers,
the formation of pyrene excited dimers is matched by
quenching of acrylodan fluorescence. Most probably,
the latter also arises from dimer formation. This is a
w xcommon mechanism of fluorescence quenching 19 ,
although we are not aware of previous reports on
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dimers of acrylodan or prodan of which acrylodan is
.a derivative . The shift in acrylodan emission that
was associated with quenching points to a possible
pitfall when employing environmentally sensitive
probes with oligomerizing proteins.
In sum, besides the central membrane-inserting
loop of a-toxin, the N-terminus constitutes the sec-
ond part of the toxin molecule to display activity
after pre-pore assembly. This is in line with the
functional interconnection between these two regions
which has been highlighted by truncation mutagene-
w x w xsis 8 and complementation of point mutations 20 .
Data are not yet available to decide if this comple-
mentation takes place within one molecule or among
adjacent subunits of the heptamer. Experiments are
under way to address this question.
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